Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: France Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20053
20071
20082
20093
20104
20112
20123
20133
20141
20154
20173
20186
20194
20201
20211
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated9
Active, not recruiting8
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Assistance Publique - Hôpitaux de Paris4
Bayer4
Bristol-Myers Squibb4
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Eli Lilly and Company2
Exelixis2
Hospices Civils de Lyon2
UNICANCER2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular47
Liver Neoplasms13
Neoplasms5
Carcinoma4
Fibrosis2
Adenocarcinoma1
Ascites1
Basal Cell Carcinoma1
Bile Duct Neoplasms1
Carcinoma, Merkel Cell1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.